CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $844 | +56.3% | 72,182 | +79.8% | 0.00% | 0.0% |
| Q2 2023 | $540 | -36.2% | 40,156 | -21.3% | 0.00% | 0.0% |
| Q1 2023 | $846 | -34.1% | 51,032 | -26.1% | 0.00% | -50.0% |
| Q4 2022 | $1,284 | -99.9% | 69,027 | +0.0% | 0.00% | +100.0% |
| Q3 2022 | $886,000 | +104.6% | 69,019 | +11.7% | 0.00% | 0.0% |
| Q2 2022 | $433,000 | -8.5% | 61,768 | +8.3% | 0.00% | 0.0% |
| Q1 2022 | $473,000 | +22.5% | 57,057 | +0.1% | 0.00% | – |
| Q4 2021 | $386,000 | +27.4% | 56,984 | -0.4% | 0.00% | – |
| Q3 2021 | $303,000 | -31.6% | 57,215 | -25.8% | 0.00% | – |
| Q2 2021 | $443,000 | +25.9% | 77,063 | +1.0% | 0.00% | – |
| Q1 2021 | $352,000 | +38.0% | 76,294 | 0.0% | 0.00% | – |
| Q4 2020 | $255,000 | +12.3% | 76,294 | 0.0% | 0.00% | – |
| Q3 2020 | $227,000 | -35.5% | 76,294 | 0.0% | 0.00% | – |
| Q2 2020 | $352,000 | +19.7% | 76,294 | 0.0% | 0.00% | – |
| Q1 2020 | $294,000 | -51.1% | 76,294 | -52.4% | 0.00% | -100.0% |
| Q4 2019 | $601,000 | +16.7% | 160,271 | +65.4% | 0.00% | 0.0% |
| Q3 2019 | $515,000 | +38.4% | 96,894 | 0.0% | 0.00% | – |
| Q2 2019 | $372,000 | -4.4% | 96,894 | +27.2% | 0.00% | – |
| Q1 2019 | $389,000 | +166.4% | 76,194 | 0.0% | 0.00% | – |
| Q4 2018 | $146,000 | -49.3% | 76,194 | 0.0% | 0.00% | – |
| Q3 2018 | $288,000 | +21.0% | 76,194 | 0.0% | 0.00% | – |
| Q2 2018 | $238,000 | +33.0% | 76,194 | +1.6% | 0.00% | – |
| Q1 2018 | $179,000 | -10.1% | 74,994 | +47.6% | 0.00% | – |
| Q4 2017 | $199,000 | +55.5% | 50,794 | 0.0% | 0.00% | – |
| Q3 2017 | $128,000 | +12.3% | 50,794 | +22.7% | 0.00% | – |
| Q2 2017 | $114,000 | +660.0% | 41,400 | +101.0% | 0.00% | – |
| Q2 2016 | $15,000 | -81.2% | 20,600 | -70.1% | 0.00% | – |
| Q1 2016 | $80,000 | -52.7% | 68,800 | 0.0% | 0.00% | – |
| Q4 2015 | $169,000 | -18.0% | 68,800 | 0.0% | 0.00% | – |
| Q3 2015 | $206,000 | +15.1% | 68,800 | +58.9% | 0.00% | – |
| Q2 2015 | $179,000 | – | 43,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |